SAPC ASM 2024 - Bristol - Talk Abstracts

Back to SAPC ASM 2024 - Bristol

  1. 7B.2
    Virtual Patients for remote learning in General Practice
  2. 7B.3
    Leadership and Management in Primary Care: Student selected component pilot study
  3. 7B.4
    Perceptions and experiences of general practice trainers and trainees of workplace-based assessment in the United Kingdom: cross sectional survey
  4. 7B.5
    How to improve communication from GPs to hospital specialists at the point of referrals? A systematic review via critical interpretive synthesis of qualitative data alongside quantitative data
  5. 7C.1
    Evaluating inventiveness in GP prescribing practice
  6. 7C.2
    Is it feasible to recruit to a cluster randomised-controlled trial to evaluate a practice pharmacist-led intervention to reduce opioid overprescribing in primary care?
  7. 7C.3
    Understanding the Challenges of Medicine Optimisation among Older People from Ethnic Minority Communities (aged 60 years and above) with Polypharmacy in Primary Care: a Realist Review
  8. 7C.4
    What are the views of the key stakeholders in deprescribing preventive medication in dementia?
  9. 7C.5
    Evaluating the National rollout of a pharmacist-led information technology intervention (PINCER) in English general practice, using a Clinical Practice Data link ‘non standard linkage’
  10. 7D.1
    Stakeholders views of the new simulated consultation assessment for GP licensing in the United Kingdom: cross sectional survey
  11. 7D.3
    Coping with General Practice: A mixed methods study
  12. 7D.4
    Trends in full-time working in general practice: repeated cross-sectional study
  13. 7D.5
    Experiences of GP trainees undertaking workplace-based assessments for general practice licensing
  14. 7E.1
    Assessing the Cardiovascular Effects of Levothyroxine Use in an Ageing United Kingdom population (ACEL-UK)
  15. 7E.2
    “We don’t need to check it, but we do check it”: Views of Primary Care Healthcare professionals on blood test monitoring in three long-term conditions
  16. 7E.3
    Implementing a clinical prediction model in primary care data to identify individuals with misclassified diabetes and increased hypoglycaemia and DKA risk
  17. 7E.4
    The effect of GLP-1 receptor agonists on liver health in participants living with overweight/obesity: a systematic review and meta-analysis.
  18. 7E.5
    Preventing steroid harms in people with polymyalgia rheumatica in English primary care – assessing the effect of prophylactic medications on fragility fractures and gastro-intestinal adverse events
  19. 8A.1
    Glucose Lowering through Weight management (GLoW): An RCT of the cost-effectiveness of a diabetes education and behavioural weight management programme versus a diabetes education programme in adults with recently diagnosed type 2 diabetes
  20. 8A.2
    Remotely-delivered weight management for people living with long COVID and overweight (ReDIRECT): a wait-list controlled randomised trial.

Pages